$5.43
0.010000.18%
At close: -
$5.36
-0.07-1.28%
After Hours: 4:49 PM EDT
Comments
Loading...
Candel Therapeutics Insider Trading Activity | NASDAQ:CADL | Benzinga
Track the latest Candel Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Candel Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Candel Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 19, 2025, Charles Schoch, the company's SEE REMARKS sold 5K shares for $8.83 each.
- On March 20, 2025, Paul Peter Tak, the company's CHIEF EXECUTIVE OFFICER sold 26.17K shares for $8.77 each.
- On March 20, 2025, Francesca Barone, the company's CHIEF SCIENTIFIC OFFICER sold 14.15K shares for $5.16 each.
Ownership Statistics for Candel Therapeutics Inc
Shares Outstanding
50.103M
Insider Shares Owned
4.810M
Insider Percentage Owned
10.2%
Institutional Shares Held
12.576M
Institutional Percentage Held
25.5%
| Mar 20, 2025 | William Garrett Nichols | CHIEF MEDICAL OFFICER | -26.83K | $5.33 | -$361.87K | SELL | -33.82% | 52.49K | Mar 18 | View |
| Mar 20, 2025 | Francesca Barone | CHIEF SCIENTIFIC OFFICER | -14.15K | $5.16 | -$253.77K | SELL | -12.78% | 96.53K | Mar 18 | View |
| Mar 20, 2025 | Paul Peter Tak | CHIEF EXECUTIVE OFFICER | -26.17K | $8.77 | -$229.62K | SELL | -10.39% | 225.74K | Mar 18 - Mar 19 | View |
| Mar 19, 2025 | Seshu Tyagarajan | CHIEF TECHNOLOGY OFFICER | -31.28K | $8.82 | -$275.95K | SELL | -26.78% | 85.51K | Mar 17 | View |
| Mar 19, 2025 | Charles Schoch | SEE REMARKS | -5.00K | $8.83 | -$44.17K | SELL | -11.62% | 38.04K | Mar 17 | View |
| Jan 17, 2025 | Francesca Barone | CHIEF SCIENTIFIC OFFICER | -13.53K | $7.22 | -$97.78K | SELL | -10.90% | 110.67K | Jan 15 | View |
| Jan 17, 2025 | Seshu Tyagarajan | CHIEF TECHNOLOGY OFFICER | -14.32K | $7.22 | -$103.48K | SELL | -12.89% | 96.79K | Jan 15 | View |
| Jan 17, 2025 | Charles Schoch | SEE REMARKS | -9.51K | $7.22 | -$68.72K | SELL | -18.10% | 43.04K | Jan 15 | View |
| Jan 17, 2025 | Paul Peter Tak | CHIEF EXECUTIVE OFFICER | -21.70K | $7.22 | -$156.81K | SELL | -7.93% | 251.91K | Jan 15 | View |
| Jan 17, 2025 | William Garrett Nichols | CHIEF MEDICAL OFFICER | -10.43K | $7.23 | -$75.34K | SELL | -11.62% | 79.32K | Jan 15 | View |
| Jan 10, 2025 | Francesca Barone | CHIEF SCIENTIFIC OFFICER | -13.67K | $8.22 | -$112.37K | SELL | -9.92% | 124.21K | Jan 08 | View |
| Jan 10, 2025 | Charles Schoch | SEE REMARKS | -9.97K | $8.22 | -$81.94K | SELL | -15.95% | 52.55K | Jan 08 | View |
| Jan 10, 2025 | Paul Peter Tak | CHIEF EXECUTIVE OFFICER | -21.17K | $8.22 | -$174.00K | SELL | -7.18% | 273.62K | Jan 08 | View |
| Jan 10, 2025 | Seshu Tyagarajan | CHIEF TECHNOLOGY OFFICER | -14.54K | $8.22 | -$119.53K | SELL | -11.58% | 111.11K | Jan 08 | View |
| Jan 10, 2025 | William Garrett Nichols | CHIEF MEDICAL OFFICER | -10.80K | $8.22 | -$88.75K | SELL | -10.74% | 89.75K | Jan 08 | View |
| Dec 18, 2024 | Paul B Manning | — | 1.25M | $6.00 | $7.50M | BUY | 72.06% | 2.98M | Dec 16 | View |
| Dec 03, 2024 | Seshu Tyagarajan | CHIEF TECHNOLOGY OFFICER | -20.39K | $4.56 | -$92.90K | SELL | -13.96% | 125.66K | Nov 29 | View |
| Dec 03, 2024 | Paul Peter Tak | CHIEF EXECUTIVE OFFICER | -48.85K | $4.56 | -$222.53K | SELL | -14.21% | 294.79K | Nov 29 | View |
| Dec 03, 2024 | William Garrett Nichols | CHIEF MEDICAL OFFICER | -13.94K | $4.56 | -$63.48K | SELL | -12.17% | 100.55K | Nov 29 | View |
| Dec 03, 2024 | Francesca Barone | CHIEF SCIENTIFIC OFFICER | -22.08K | $4.56 | -$100.59K | SELL | -13.80% | 137.88K | Nov 29 | View |
| Oct 15, 2024 | Estuardo AguilarCordovaLaura Aguilar | 10% OWNER | -40.41K | $6.03 | -$243.83K | SELL | -3.57% | 1.09M | Oct 11 - Oct 15 | View |
| Oct 03, 2024 | Estuardo AguilarCordovaLaura Aguilar | 10% OWNER | -22.57K | $6.96 | -$155.53K | SELL | -1.96% | 1.13M | Oct 01 - Oct 03 | View |
| Jul 19, 2024 | Seshu Tyagarajan | CHIEF TECHNOLOGY OFFICER | -14.85K | $6.47 | -$96.12K | SELL | -9.23% | 146.05K | Jul 17 | View |
| Jul 19, 2024 | Paul Peter Tak | CHIEF EXECUTIVE OFFICER | -22.53K | $6.47 | -$145.81K | SELL | -6.38% | 330.74K | Jul 17 | View |
| Jul 19, 2024 | Charles Schoch | SEE REMARKS | -9.88K | $6.47 | -$63.98K | SELL | -13.65% | 62.52K | Jul 17 | View |
| Jul 19, 2024 | William Garrett Nichols | CHIEF MEDICAL OFFICER | -10.88K | $6.47 | -$70.39K | SELL | -8.68% | 114.48K | Jul 17 | View |
| Jul 19, 2024 | Francesca Barone | CHIEF SCIENTIFIC OFFICER | -14.05K | $6.47 | -$90.95K | SELL | -8.07% | 159.96K | Jul 17 | View |
| Jul 15, 2024 | Seshu Tyagarajan | CHIEF TECHNOLOGY OFFICER | -13.33K | $5.97 | -$79.63K | SELL | -7.65% | 160.90K | Jul 11 | View |
| Jul 15, 2024 | Paul Peter Tak | CHIEF EXECUTIVE OFFICER | -20.29K | $5.97 | -$121.22K | SELL | -5.43% | 353.26K | Jul 11 | View |
| Jul 15, 2024 | Charles Schoch | SEE REMARKS | -8.90K | $5.97 | -$53.15K | SELL | -10.94% | 72.40K | Jul 11 | View |
| Jul 15, 2024 | William Garrett Nichols | CHIEF MEDICAL OFFICER | -9.77K | $5.97 | -$58.35K | SELL | -7.23% | 125.36K | Jul 11 | View |
| Jul 15, 2024 | Francesca Barone | CHIEF SCIENTIFIC OFFICER | -12.64K | $5.97 | -$75.53K | SELL | -6.77% | 174.01K | Jul 11 | View |
| Dec 12, 2022 | Francesca Barone | CHIEF SCIENTIFIC OFFICER | 1.24K | $1.61 | $1.99K | BUY | 82.53% | 2.74K | Dec 08 | View |
| Dec 12, 2022 | Joseph C Papa | DIRECTOR | 38.03K | $1.92 | $73.06K | BUY | ∞ | 38.03K | Dec 08 - Dec 09 | View |
| Dec 12, 2022 | Christopher Martell | DIRECTOR | 27.00K | $1.89 | $51.11K | BUY | 21.60% | 152.00K | Dec 08 - Dec 09 | View |
| Dec 12, 2022 | Paul Peter Tak | CHIEF EXECUTIVE OFFICER | 15.98K | $1.88 | $30.02K | BUY | 63.94% | 40.98K | Dec 08 - Dec 09 | View |
| Dec 12, 2022 | Seshu Tyagarajan | CHIEF TECHNOLOGY OFFICER | 13.36K | $1.88 | $25.06K | BUY | ∞ | 13.36K | Dec 08 - Dec 09 | View |
| Dec 12, 2022 | Jason Amello | CHIEF FINANCIAL OFFICER | 5.57K | $1.80 | $10.00K | BUY | ∞ | 5.57K | Dec 08 - Dec 09 | View |
| Aug 02, 2021 | Christopher Martell | DIRECTOR | 408.51K | $8.00 | $1.00M | BUY | ∞ | 125.00K | Jul 29 | View |
| Aug 02, 2021 | Diem Nguyen | DIRECTOR | 10.00K | $8.00 | $80.00K | BUY | ∞ | 10.00K | Jul 29 | View |
| Aug 02, 2021 | Peter Paul Tak | CHIEF EXECUTIVE OFFICER | 25.00K | $8.00 | $200.00K | BUY | ∞ | 25.00K | Jul 29 | View |
| Aug 02, 2021 | John Canepa | CHIEF FINANCIAL OFFICER | 10.13K | $8.00 | $81.00K | BUY | ∞ | 10.13K | Jul 29 | View |
| Aug 02, 2021 | Nathan Caffo | CHIEF BUSINESS OFFICER | 6.00K | $8.00 | $48.00K | BUY | ∞ | 6.00K | Jul 29 | View |
| Jul 29, 2021 | Paul Manning | DIRECTOR | 56.00K | $7.34 | $410.78K | BUY | ∞ | 56.00K | Jul 27 - Jul 29 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
